Rare tumors in children

Progress through collaboration

Alberto S. Pappo, Wayne L. Furman, Kris A. Schultz, Andrea Ferrari, Lee Helman, Mark D. Krailo

Research output: Contribution to journalArticle

17 Citations (Scopus)

Abstract

Rare pediatric tumors account for approximately 10% of all childhood cancers, which in themselves are a rare entity. The diverse histologies and clinical behaviors of rare pediatric tumors pose challenges to the investigation of their biologic and clinical features. National and international cooperative groups such as the Rare Tumor Committee of the Children's Oncology Group, Rare Tumors in Pediatric Age Project, and European Cooperative Study Group for Pediatric Rare Tumors have developed several initiatives to advance knowledge about rare pediatric cancers. However, these programs have been only partially effective, necessitating the development of alternative mechanisms to study these challenging diseases. In this article, we review the current national and international collaborative strategies to study rare pediatric cancers and alternative methods under exploration to enhance those efforts, such as independent registries and disease-specific, National Cancer Institute-sponsored clinics.

Original languageEnglish
Pages (from-to)3047-3054
Number of pages8
JournalJournal of Clinical Oncology
Volume33
Issue number27
DOIs
Publication statusPublished - Sep 20 2015

Fingerprint

Pediatrics
Neoplasms
National Cancer Institute (U.S.)
Registries
Histology

ASJC Scopus subject areas

  • Cancer Research
  • Oncology
  • Medicine(all)

Cite this

Pappo, A. S., Furman, W. L., Schultz, K. A., Ferrari, A., Helman, L., & Krailo, M. D. (2015). Rare tumors in children: Progress through collaboration. Journal of Clinical Oncology, 33(27), 3047-3054. https://doi.org/10.1200/JCO.2014.59.3632

Rare tumors in children : Progress through collaboration. / Pappo, Alberto S.; Furman, Wayne L.; Schultz, Kris A.; Ferrari, Andrea; Helman, Lee; Krailo, Mark D.

In: Journal of Clinical Oncology, Vol. 33, No. 27, 20.09.2015, p. 3047-3054.

Research output: Contribution to journalArticle

Pappo, AS, Furman, WL, Schultz, KA, Ferrari, A, Helman, L & Krailo, MD 2015, 'Rare tumors in children: Progress through collaboration', Journal of Clinical Oncology, vol. 33, no. 27, pp. 3047-3054. https://doi.org/10.1200/JCO.2014.59.3632
Pappo, Alberto S. ; Furman, Wayne L. ; Schultz, Kris A. ; Ferrari, Andrea ; Helman, Lee ; Krailo, Mark D. / Rare tumors in children : Progress through collaboration. In: Journal of Clinical Oncology. 2015 ; Vol. 33, No. 27. pp. 3047-3054.
@article{bdafa0d2b0dd463ba1f76f7c15675d8d,
title = "Rare tumors in children: Progress through collaboration",
abstract = "Rare pediatric tumors account for approximately 10{\%} of all childhood cancers, which in themselves are a rare entity. The diverse histologies and clinical behaviors of rare pediatric tumors pose challenges to the investigation of their biologic and clinical features. National and international cooperative groups such as the Rare Tumor Committee of the Children's Oncology Group, Rare Tumors in Pediatric Age Project, and European Cooperative Study Group for Pediatric Rare Tumors have developed several initiatives to advance knowledge about rare pediatric cancers. However, these programs have been only partially effective, necessitating the development of alternative mechanisms to study these challenging diseases. In this article, we review the current national and international collaborative strategies to study rare pediatric cancers and alternative methods under exploration to enhance those efforts, such as independent registries and disease-specific, National Cancer Institute-sponsored clinics.",
author = "Pappo, {Alberto S.} and Furman, {Wayne L.} and Schultz, {Kris A.} and Andrea Ferrari and Lee Helman and Krailo, {Mark D.}",
year = "2015",
month = "9",
day = "20",
doi = "10.1200/JCO.2014.59.3632",
language = "English",
volume = "33",
pages = "3047--3054",
journal = "Journal of Clinical Oncology",
issn = "0732-183X",
publisher = "American Society of Clinical Oncology",
number = "27",

}

TY - JOUR

T1 - Rare tumors in children

T2 - Progress through collaboration

AU - Pappo, Alberto S.

AU - Furman, Wayne L.

AU - Schultz, Kris A.

AU - Ferrari, Andrea

AU - Helman, Lee

AU - Krailo, Mark D.

PY - 2015/9/20

Y1 - 2015/9/20

N2 - Rare pediatric tumors account for approximately 10% of all childhood cancers, which in themselves are a rare entity. The diverse histologies and clinical behaviors of rare pediatric tumors pose challenges to the investigation of their biologic and clinical features. National and international cooperative groups such as the Rare Tumor Committee of the Children's Oncology Group, Rare Tumors in Pediatric Age Project, and European Cooperative Study Group for Pediatric Rare Tumors have developed several initiatives to advance knowledge about rare pediatric cancers. However, these programs have been only partially effective, necessitating the development of alternative mechanisms to study these challenging diseases. In this article, we review the current national and international collaborative strategies to study rare pediatric cancers and alternative methods under exploration to enhance those efforts, such as independent registries and disease-specific, National Cancer Institute-sponsored clinics.

AB - Rare pediatric tumors account for approximately 10% of all childhood cancers, which in themselves are a rare entity. The diverse histologies and clinical behaviors of rare pediatric tumors pose challenges to the investigation of their biologic and clinical features. National and international cooperative groups such as the Rare Tumor Committee of the Children's Oncology Group, Rare Tumors in Pediatric Age Project, and European Cooperative Study Group for Pediatric Rare Tumors have developed several initiatives to advance knowledge about rare pediatric cancers. However, these programs have been only partially effective, necessitating the development of alternative mechanisms to study these challenging diseases. In this article, we review the current national and international collaborative strategies to study rare pediatric cancers and alternative methods under exploration to enhance those efforts, such as independent registries and disease-specific, National Cancer Institute-sponsored clinics.

UR - http://www.scopus.com/inward/record.url?scp=84942236059&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84942236059&partnerID=8YFLogxK

U2 - 10.1200/JCO.2014.59.3632

DO - 10.1200/JCO.2014.59.3632

M3 - Article

VL - 33

SP - 3047

EP - 3054

JO - Journal of Clinical Oncology

JF - Journal of Clinical Oncology

SN - 0732-183X

IS - 27

ER -